VAGINEX W TRIPELENNAMINE CRM 2% DIN 00584096
Status: Cancelled Post Market
Holder: JULIUS SCHMID CANADA LTD.
Molecule: TRIPELENNAMINE HYDROCHLORIDE
Health Canada record
| Active ingredient(s) | TRIPELENNAMINE HYDROCHLORIDE 2 % |
|---|---|
| Dosage form | Cream |
| Route | Vaginal |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | |
| Original market date | 31-Dec-1984 |
| Current status date | 07-Aug-1997 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TRIPELENNAMINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02428407 | BUG BITE BALM | MAGICALLY GONE INC | Cream | TRIPELENNAMINE HYDROCHLORIDE 1.00 % | Cancelled (Unreturned Annual) |
| 00623504 | PYRIBENZAMINE TAB 50MG | NOVARTIS CONSUMER HEALTH CANADA INC. | Tablet | TRIPELENNAMINE HYDROCHLORIDE 50 MG | Cancelled Post Market |
| 02239338 | VAGIN-X | ASSOCIATED NATIONAL BROKERAGE INC. | Cream | TRIPELENNAMINE HYDROCHLORIDE 2 % | Cancelled Post Market |
| 00170801 | VETASTIM 20MG/CC | ROGAR/STB INC. | Liquid | TRIPELENNAMINE HYDROCHLORIDE 20 MG | Cancelled Post Market |
International API supply for TRIPELENNAMINE HYDROCHLORIDE
0 active FDA Drug Master Files.
Request a quote for VAGINEX W TRIPELENNAMINE CRM 2%